TFEC
Transcription factor EC
Also known as: bHLHe34, TCFEC, TFEC_HUMAN, TFECL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14948
- Gene
- TFEC
- Ensembl
- ENSG00000105967
- Chromosome
- 7
- Canonical length
- 347 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the micropthalmia (MiT) family of basic helix-loop-helix leucine zipper transcription factors. MiT transcription factors regulate the expression of target genes by binding to E-box recognition sequences as homo- or heterodimers, and play roles in multiple cellular processes including survival, growth and differentiation. The encoded protein is a transcriptional activator of the nonmuscle myosin II heavy chain-A gene, and may also co-regulate target genes in osteoclasts as a heterodimer with micropthalmia-associated transcription factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>O14948|TFEC
1 MTLDHQIINP TLKWSQPAVP SGGPLVQHAH TTLDSDAGLT ENPLTKLLAI GKEDDNAQWH
61 MEDVIEDIIG MESSFKEEGA DSPLLMQRTL SGSILDVYSG EQGISPINMG LTSASCPSSL
121 PMKREITETD TRALAKERQK KDNHNLIERR RRYNINYRIK ELGTLIPKSN DPDMRWNKGT
181 ILKASVEYIK WLQKEQQRAR ELEHRQKKLE QANRRLLLRI QELEIQARTH GLPTLASLGT
241 VDLGAHVTKQ QSHPEQNSVD YCQQLTVSQG PSPELCDQAI AFSDPLSYFT DLSFSAALKE
301 EQRLDGMLLD DTISPFGTDP LLSATSPAVS KESSRRSSFS SDDGDELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TFEC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 21 nTPM
- kidney: 19 nTPM
- appendix: 18 nTPM
- bone marrow: 16 nTPM
- spleen: 14 nTPM
- tonsil: 12 nTPM
Single-cell type
- microglia: 237 nCPM
- macrophages: 218 nCPM
- monocyte progenitors: 205 nCPM
- monocytes: 177 nCPM
- hematopoietic stem cells: 166 nCPM
- kupffer cells: 153 nCPM
Immune cell
- classical monocyte: 7.1 nTPM
- myeloid DC: 6.3 nTPM
- memory B-cell: 3.8 nTPM
- plasmacytoid DC: 3.3 nTPM
- intermediate monocyte: 2.8 nTPM
- naive B-cell: 2.5 nTPM
Brain region
- white matter: 10 nTPM
- thalamus: 8.7 nTPM
- medulla oblongata: 7.1 nTPM
- pons: 6.1 nTPM
- spinal cord: 6.1 nTPM
- choroid plexus: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to heat
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TFEC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TFEC as an antibody target. Whether an autoantibody or antibody against TFEC could matter depends on whether native TFEC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TFEC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TFEC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...